Combination LAG-3/PD-1 inhibition superior to PD-1 inhibition monotherapy for metastatic melanoma
Findings from a new study suggest that inhibiting both the LAG-3 and PD-1 immune checkpoints in patients with previously untreated...
top of page
it's where dermatology lives
Featured Posts
bottom of page